RYTM
Rhythm Pharmaceuticals Inc
92.80$
-0.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -130.0% | -121.2% | -156.9% | -100.0% | -75.8% | -45.1% | -123.4% | -48.1% | -51.9% | -44.3% | -73.5% | -74.9% | -62.3% | |
| 2.0% | 1.7% | 1.6% | 1.3% | 1.2% | 0.9% | 1.2% | 0.8% | 0.6% | 0.5% | 0.4% | 0.7% | 0.6% | |
| 38.3% | 35.8% | 29.9% | 35.6% | 33.1% | 25.2% | 39.3% | 32.7% | 36.7% | 33.7% | 38.4% | 69.0% | 46.0% | |
| -7.0% | 36.8% | -8.4% | -7.4% | 14.1% | 24.4% | -24.2% | 9.3% | 6.1% | -1.2% | -28.3% | -8.9% | -8.7% | |
| 0.0% | 0.0% | 154.0% | 0.0% | 120.3% | 0.0% | 0.0% | 0.0% | 0.0% | 1.7% | 0.0% | 0.0% | 0.4% | |
| -422.0% | 93.4% | 115.7% | -29.4% | -273.1% | 50.6% | 75.9% | 111.4% | -480.2% | 53.0% | 94.9% | 99.7% | -36.6% | |
| – | – | – | – | 7.9% | – | – | 5.5% | 2.7% | 0.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -1.8% | – | |
| 324.6% | 10.0% | 16.3% | 502.7% | 7.5% | 91.6% | 99.4% | -1.8% | 369.0% | -5.1% | -9.0% | -9.2% | 72.7% | |
| -227.0% | -18.6% | -25.1% | 372.2% | -343.3% | 99.5% | 51.9% | 60.9% | -162.5% | 3.9% | 13.0% | 16.0% | -25.8% | |
| -130.0% | -121.2% | -310.9% | -100.0% | -75.8% | -45.1% | -123.4% | -48.1% | -51.9% | -46.0% | -73.5% | -74.9% | -62.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.